Clinical Trial Update: Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates completion of Phase 1/2 studies evaluating etanercept for non-infectious lung injury after bone marrow transplantation. The cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Pneumonia
• Respiratory Distress Syndrome

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Respiratory Distress Syndrome, Adult, Bronchiolitis Obliterans | Phase 1, Phase 2 | Status: COMPLETED